IMPORTANT MESSAGE REGARDING COVID-19

We hold pharmaceutical companies responsible for opioid-induced illness.

Elmiron and Eye Damage

Elmiron received FDA approval in 1996 as a treatment for interstitial cystitis (IC), a bladder pain syndrome. After more than 20 years of use, however, researchers at Emory University in 2018 reported on six adult women patients with a unique type of degenerative visual disorder –- pigmentary maculopathy – that they linked to their patients’ chronic use of Elmiron.

The macula is the central area of the retina, the region of keenest vision. Pigmentary maculopathy is a form of macular degeneration that can result in irreversible retina damage, vision loss and blindness.

Symptoms include:

  • blurry vision,
  • night blindness,
  • difficulty reading,
  • loss of vision detail, and
  • dark spots on the retina.

Elmiron, manufactured by Janssen Pharmaceuticals, a division of Johnson & Johnson, is Pentosan Polysulfate Sodium (PPS), and was initially used for its anticoagulant properties in the treatment of varicose veins.

It was later found that the drug could provide clinical benefit for patients suffering IC, a condition that has been estimated to affect more than 1 million people in the United States, predominantly women. Elmiron remains the only FDA-approved drug for the management of IC.

Since 2018, there have been more than a dozen published reports and papers confirming the link between the long-term use of Elmiron and vision problems from maculopathy. These studies have shown that up to 25% of chronic users of Elmiron are afflicted with this condition.

Researchers suggest that long-term users of Elmiron who notice vision changes should undergo an eye examination with retinal imaging. The diagnosis of pigmentary maculopathy is usually made after imaging studies and a consultation with a retina specialist.

How Waters Kraus & Paul can help

For over 20 years, Waters Kraus & Paul has represented people affected by unsafe products, such as dangerous pharmaceuticals and faulty medical devices. We are the only plaintiffs’ law firm to obtain a verdict in a PPA (phenylpropanolamine)/stroke case against Bayer, the pharmaceutical maker. Our drug injury lawyers stood up for families whose children suffered blistering skin reactions after taking prescription drugs. With a national presence and a wealth of experience, our firm has the resources to champion your case in any court in the country. To have one of our lawyers review your potential Elmiron case, email us or call 800.226.9880.

Elmiron Eye Damage Symptoms:

  • Blindness
  • Dark Spots
  • Blurry Vison
  • Night Blindness
  • Visual Dimming
  • Difficulty Reading
  • Loss of Close Vision

Zostavax Lawsuits and New Alternative for Shingles Vaccine

September 5, 2019 Merck is facing 57 federal lawsuits, alleging that 117 people suffered injuries after receiving the Zostavax vaccine. The individuals in these lawsuits claim that their injuries were caused by the live shingles virus in the vaccine. From the time Zostavax…

Texas in Violation of Voting Registration Law

August 31, 2020 For a second time, a federal judge finds Texas is in violation of the federal voter registration law. In a 68-page ruling Friday, Aug. 28, 2020, U.S. District Judge Orlando Garcia of San Antonio found that the State of Texas continues…

Peter Kraus to Appear on the 2020 Best Lawyers in Dallas List

September 9, 2020 Peter Kraus, a founding and managing partner of Waters & Kraus, LLP has been selected to appear on D Magazine’s Best Lawyers in Dallas 2020 list under the category of tort and product liability. The distinguished honor is accorded to only the top 4% of the nearly 20,000 attorneys residing in Dallas and Collin counties. Peter has represented numerous clients in matters involving toxic torts, False Claim whistleblower cases and pharmaceutical injury litigation. He graduated from Duke University with his bachelor’s degree, and then went on to the University of Texas where he earned his Juris Doctor degree. Though a…
Waters Kraus & Paul

What are my chances?

That’s the first question everyone asks. The truth is it’s impossible to know. But we can tell you this. Waters Kraus & Paul has what it takes to fight against big corporate interests and win. That’s why we’ve taken more mesothelioma trials to verdict than any other firm. And that’s why we’ve recovered more than $1.3 billion for clients like you. Do you think you have a case? Contact us now to speak with an attorney.

Call 800.226.9880